Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI
暂无分享,去创建一个
Irina Proskorovsky | David J. Cohen | Elizabeth M. Mahoney | Elliott Antman | E. Antman | E. Braunwald | E. Mahoney | S. Arnold | D. Cohen | S. Wiviott | Eugene Braunwald | I. Proskorovsky | Kaijun Wang | Suzanne V. Arnold | Stephen Wiviott | Kaijun Wang | D. Cohen | D. Cohen
[1] A S Detsky,et al. Treatment of Chronic Nonvalvular Atrial Fibrillation in the Elderly , 1992, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] S. Yusuf,et al. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.
[3] Deepak L. Bhatt,et al. One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States , 2008, Circulation. Cardiovascular quality and outcomes.
[4] R. Klein,et al. The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[5] V. Serebruany. The FDA Prasugrel Review: Adjudication of Myocardial Infarction Controversy , 2009, Cardiology.
[6] A. Newman,et al. Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure: The Sleep Heart Health Study , 2010, Circulation.
[7] Olli Saarela,et al. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.
[8] Jeffrey Gold,et al. Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery: What Happens in Actual Practice? , 2010, Circulation.
[9] Uwe Siebert,et al. Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease , 2010, Circulation.
[10] Sanghamitra Mohanty,et al. Left Atrial Appendage: An Underrecognized Trigger Site of Atrial Fibrillation , 2010, Circulation.
[11] V. Fowler,et al. Analysis of the Impact of Early Surgery on In-Hospital Mortality of Native Valve Endocarditis: Use of Propensity Score and Instrumental Variable Methods to Adjust for Treatment-Selection Bias , 2010, Circulation.
[12] B. Gersh,et al. Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2010, Circulation.
[13] Joseph Varon,et al. Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe Hypertension , 2010, Circulation.
[14] M. Cheitlin. Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction , 2011 .
[15] S. Yusuf,et al. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation. , 2006, American heart journal.
[16] V. Serebruany,et al. Prasugrel as a potential cancer promoter: review of the unpublished data. , 2010, Archives of internal medicine.
[17] L Goldman,et al. Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] Sheng-Chia Chung,et al. Health Status After Treatment for Coronary Artery Disease and Type 2 Diabetes Mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial , 2010, Circulation.
[19] M. Keltai,et al. Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .
[20] M. Chung,et al. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.
[21] Andreas Metzner,et al. Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons From a 5-Year Follow-Up , 2010, Circulation.
[22] David A. Morrow,et al. Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN , 2010, Circulation.
[23] Kenneth C Bilchick,et al. Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients , 2010, Circulation.
[24] S. Yusuf,et al. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. , 2005, Journal of the American College of Cardiology.
[25] B. Yawn,et al. Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction , 2010, Circulation.
[26] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.
[27] S. Normand,et al. Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries: Progress and Continuing Challenges , 2010, Circulation.
[28] M. Prins,et al. Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A , 2010, Circulation.
[29] E. Antman,et al. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial , 2008, European heart journal.
[30] Jonathan H. Gillard,et al. Association Between Aneurysm Shoulder Stress and Abdominal Aortic Aneurysm Expansion: A Longitudinal Follow-Up Study , 2010, Circulation.
[31] E. Hannan,et al. Temporal Trends in the Use of Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery in New York State and Ontario , 2010, Circulation.
[32] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.
[33] A. Sharrett,et al. Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals , 2010, Circulation.
[34] Ronen Gurvitch,et al. Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves , 2010, Circulation.
[35] M. Maeng,et al. Primary Angioplasty Versus Fibrinolysis in Acute Myocardial Infarction: Long-Term Follow-Up in the Danish Acute Myocardial Infarction 2 Trial , 2010, Circulation.
[36] G. Moneta. Association Between Aneurysm Shoulder Stress and Abdominal Aortic Aneurysm Expansion: A Longitudinal Follow-Up Study , 2011 .
[37] Diane M. Miller,et al. Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial , 2010, Circulation.
[38] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[39] B. Efron. Better Bootstrap Confidence Intervals , 1987 .
[40] G. Lamas,et al. Impact of Collateral Flow to the Occluded Infarct-Related Artery on Clinical Outcomes in Patients With Recent Myocardial Infarction: A Report From the Randomized Occluded Artery Trial , 2010, Circulation.
[41] S. Kimmel,et al. Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.
[42] A. Kamarulzaman. International Collaboration on Endocarditis Prospective Cohort Study , 2008 .
[43] Deepak L. Bhatt,et al. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[44] W. Strohsnitter,et al. Anomalous Mitral Arcade in Twin-Twin Transfusion Syndrome , 2010, Circulation.
[45] R. McKelvie,et al. Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial , 2010, Circulation.
[46] Xiao-fu Dai,et al. Extensive Primary Repair of the Thoracic Aorta in Acute Type A Aortic Dissection by Means of Ascending Aorta Replacement Combined With Open Placement of Triple-Branched Stent Graft: Early Results , 2010, Circulation.
[47] Jackie A Cooper,et al. PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry , 2010, Circulation.
[48] M. Gold. Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator: An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II , 2011 .
[49] D. Cohen,et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. , 2008, The Annals of thoracic surgery.
[50] S. Yusuf,et al. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.
[51] M. Schieber,et al. Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.
[52] Georg Heinze,et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.
[53] Tammy O. Tengs,et al. A Meta-Analysis of Quality-of-Life Estimates for Stroke , 2012, PharmacoEconomics.
[54] P. Beck,et al. Health Databases in Saskatchewan , 2002 .
[55] Deepak L. Bhatt,et al. Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial , 2010 .
[56] A Briggs,et al. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.
[57] H. White,et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. , 2007, Journal of the American College of Cardiology.
[58] J. Caro,et al. Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[59] G. Divine,et al. Multicenter Cluster-Randomized Trial of a Multifactorial Intervention to Improve Antihypertensive Medication Adherence and Blood Pressure Control Among Patients at High Cardiovascular Risk (The COM99 Study) , 2010, Circulation.
[60] E. Antman,et al. Mortality in the TRITON trial: update from the FDA prasugrel action package. , 2010, The American journal of cardiology.
[61] S. Connolly,et al. Mechanisms Underlying the Lack of Effect of Implantable Cardioverter-Defibrillator Therapy on Mortality in High-Risk Patients With Recent Myocardial Infarction: Insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT) , 2010, Circulation.
[62] T. Kume,et al. Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents: Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) , 2010, Circulation.
[63] H. Sipilä,et al. Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.
[64] E. Topol,et al. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. , 2004, Journal of the American College of Cardiology.
[65] L. Køber,et al. Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke , 2010, Circulation.
[66] T. Akasaka,et al. Prevalence and Clinical Significance of Papillary Muscle Infarction Detected by Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With ST-Segment Elevation Myocardial Infarction , 2010, Circulation.
[67] Brandon K. Fornwalt,et al. Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy , 2010, Circulation.
[68] Demosthenes B Panagiotakos,et al. Exercise capacity and mortality in older men: a 20-year follow-up study. , 2010, Circulation.
[69] C. Cannon,et al. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis , 2010, Circulation.
[70] A. Kastrati,et al. Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement , 2010, Circulation.
[71] Jeroen J. Bax,et al. Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left Ventricular Reverse Volumetric Remodeling During Cardiac Resynchronization Therapy , 2010, Circulation.